2024 — Using artificial intelligence technology to identify patterns of DNA fragments associated with lung cancer, researchers have developed and validated a liquid biopsy that may help identify ...
Biofidelity, a leader in innovative genomic solutions, today announced the launch of Aspyre Lung Reagents (research use only) for liquid biopsy samples. Aspyre Lung identifies established non-small ...
The FDA has approved FoundationOne Liquid CDx as a companion diagnostic for patients with metastatic non–small cell lung ...
This helps provide better diagnosis, with at least 100 times more information than the current liquid biopsy testing ... The ...
"Our mission is to make cancer less deadly through widely accessible next-generation early detection blood tests." Susan Tousi, CEO of Delfi Diagnostics, tells Bloomberg Intelligence in this episode ...
New study introduces a simple blood test to detect early lung damage in cancer patients receiving novel ... University ...
In recent research published in eGastroenterology, Dr. J-Matthias Löhr and colleagues provide an in-depth review of ...
A breakthrough AI-powered liquid biopsy combining cell-free DNA and protein biomarkers improves early detection of ovarian ...
Liquid Biopsy MarketThe global liquid biopsy market is projected to experience remarkable growth, with an estimated revenue ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback